The vav gene is expressed in all hematopoietic but few other cell type
s. To explore its unusual compartment-wide regulation, We cloned the m
urine gene, sequenced its promoter region, identified DNase I hypersen
sitive (HS) sites in the chromatin, and tested their promoter activity
with a beta-galactosidase (beta-gal) reporter gene in cell lines and
transgenic mice. Whereas fibroblasts had no HS sites, a myeloid and an
erythroid cell line contained five, located 0.2 kb (HS1), 1.9 kb (HS2
), and 3.6 kb (HS3) upstream from the transcription start and 0.6 kb (
HS4) and 10 kb (HS5) downstream. A vav DNA fragment including HS1 prom
oted beta-gal expression in a myeloid but not a fibroblast line. Expre
ssion in leukocytes of transgenic mice also required HS2 and HS5. Only
hematopoietic organs contained beta-gal, but virtually all beta-gal() cells were B or T lymphocytes. Expression was always variegated (mos
aic), and the proportion of beta-gal(+) cells declined with lymphoid m
aturation and animal age. Thus, these vav regulatory elements promoted
hematopoietic-specific expression in vivo, at least in lymphocytes, b
ut the transgene was sporadically silenced. Maintaining pan-hematopoie
tic expression may require additional vav elements or an alternative r
eporter. (C) 1998 by The American Society of Hematology.